Latest Boehringer Ingelheim Stories
Legal-Bay, Lawsuit Money Advance Firm, says Boehringer submitted a supplemental new drug application to the FDA for Pradaxa so it can be used to treat the prophylaxis of deep venous thrombosis (DVT)
VANCOUVER, British Columbia, March 31, 2015 /PRNewswire/ -- InMed Pharmaceuticals Inc.
- Nearly double the percentage of patients on BI 655066 with clear or almost clear skin (PASI 90) after 12 weeks vs.
-- Data show initial therapy in newly diagnosed NVAF patients diverged from guideline recommendations RIDGEFIELD, Conn., March 16, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals,
BOCA RATON, Fla., March 12, 2015 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for dabigatran etexilate
RANCHO CORDOVA, Calif., March 10, 2015 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC) has announced that Don Whiteaker has joined AFC as Senior Director Supply Chain.
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 says the strong preference for generic drugs is the major market driver while and the strong focus on the high - potency API is the
- Growing in low tufty patches.